1. NSAIDs: Risk of acute MI compared with remote use
Unadjusted odds ratio
Adjusted odds ratio
95% CI p
Indomethacin
1.65
1.71
<0.0001
Sulindac
1.46
1.41
0.04
Meloxicam
1.34
1.37
0.02
Rofecoxib
1.32
Piroxicam
1.14
1.18
0.22
Other NSAIDs
1.22
0.15
Singh G, et al. EULAR 2005; June 8-11, 2005; Vienna, Austria.

2. NSAIDs: Risk of acute MI compared with remote use
Unadjusted odds ratio
Adjusted odds ratio
95% CI p
Ibuprofen
1.08
1.11
0.02
Celecoxib
1.09
0.008
Naproxen
1.03
0.22
Diclofenac
1.04
1.05
0.43
Valdecoxib
0.99
0.97
Ketoprofen
0.88
0.86
0.35
Nabumetone
0.83
0.26
Singh G, et al. EULAR 2005; June 8-11, 2005; Vienna, Austria.

3. NSAID use in cohort study
Drug use
Patients
Patient-years
Percentage of cohort
Celecoxib
46.04
Diclofenac
44 488
16.82
Ibuprofen
57.03
Indomethacin
40 168
9266
6.17
Ketoprofen
18 575
7577
2.86
Meloxicam
26 123
8413
4.02
Nabumetone
25 286
8368
3.89
Naproxen
51 645
26.48
Singh G, et al. EULAR 2005; June 8-11, 2005; Vienna, Austria.

4. NSAID use in cohort study
Drug use
Patients
Patient-years
Percentage of cohort
Other NSAIDs
90 539
32 832
13.92
Piroxicam
22 212
9243
3.41
Rofecoxib
32.27
Sulindac
15 906
6087
2.44
Valdecoxib
26 526
6161
4.08
Total
Aspirin
31.24
Singh G, et al. EULAR 2005; June 8-11, 2005; Vienna, Austria.